Pro Health Tips
Monday, 4 June 2018
FGFR-targeted Therapy More Beneficial to Urothelial Patients Compared to Immunotherapy
Phase II clinical trial results suggest that FGFR inhibitor may benefit patients when immunotherapy fails.
from Medindia Health News https://ift.tt/2JonmOv
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Phase II clinical trial results suggest that FGFR inhibitor may benefit patients when immunotherapy fails.
No comments:
Post a Comment